Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
about
Prion protein-specific antibodies that detect multiple TSE agents with high sensitivityPentosan Polysulfate: Oral Versus Subcutaneous Injection in Mucopolysaccharidosis Type I DogsThe efficacy of tetracyclines in peripheral and intracerebral prion infection.From high-throughput cell culture screening to mouse model: identification of new inhibitor classes against prion disease.Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity.Sulfated dextrans enhance in vitro amplification of bovine spongiform encephalopathy PrP(Sc) and enable ultrasensitive detection of bovine PrP(Sc).Postmortem findings in a case of variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulfate.Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting diseaseA porphyrin increases survival time of mice after intracerebral prion infectionVariant CJD. 18 years of research and surveillance.Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides.Experimental treatments for human transmissible spongiform encephalopathies: is there a role for pentosan polysulfate?Enhanced antiscrapie effect using combination drug treatmentRapidly progressive dementias and the treatment of human prion diseases.Therapeutic approaches for prion disorders.Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice.Therapeutic interventions ameliorating prion disease.Insights from Therapeutic Studies for PrP Prion Disease.Regulation of prion protein expression: a potential site for therapeutic intervention in the transmissible spongiform encephalopathies.Long term survival in a patient with variant Creutzfeldt-Jakob disease treated with intraventricular pentosan polysulphate.
P2860
Q27316704-E0330CFE-4AE2-4437-9219-1095A58A6E09Q28551264-411F72CC-B257-4C65-A03D-5DC324DC2693Q30496598-9B4F3E86-F981-4191-9F66-FAF27B6F3908Q31023317-6F6C798A-72BF-4F01-BA89-8243AD579461Q33560026-9D4C598F-1127-4A35-845A-2FAF08B20C1CQ33722019-5C082948-8F33-4700-9D74-F43AB04DCCBAQ33956775-523AB361-B39F-4E47-8CAE-674EB5D9EB26Q34301796-8C3ED7AB-B840-4087-981C-AB9C134F35FBQ34352240-00FE5E7C-AD34-4D3D-99AA-C7C51AB4B546Q34453109-39304E63-294F-47C2-815F-C6AB60277909Q34509751-61416686-7E0A-40E6-BAF3-86CF2C10D1D1Q34625274-535CE8CD-A0B6-4EAA-96AD-EA1499DCDE65Q35091582-3B29DAD4-EBE0-43DC-B554-700D89737F31Q35832931-1A743F70-7A76-4746-B0C2-658C4206D23FQ36901944-13FF29E0-46E9-45D3-9FDE-9F156E39E4B2Q37080697-29412080-8052-46AC-A3E4-AAD1E07AEA07Q37557690-6D48237F-68CB-43EB-AE01-2A047406652DQ39005891-740E0D53-4F7E-40E6-BDCE-09452C680617Q39525177-5C03378B-B9A4-4556-8EB9-FB24B7094E35Q42765732-64706607-1C8E-4C9A-A4BD-DCFAF23551F0
P2860
Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cerebroventricular infusion of ...... ant Creutzfeldt-Jakob disease.
@en
Cerebroventricular infusion of ...... ant Creutzfeldt-Jakob disease.
@nl
type
label
Cerebroventricular infusion of ...... ant Creutzfeldt-Jakob disease.
@en
Cerebroventricular infusion of ...... ant Creutzfeldt-Jakob disease.
@nl
prefLabel
Cerebroventricular infusion of ...... ant Creutzfeldt-Jakob disease.
@en
Cerebroventricular infusion of ...... ant Creutzfeldt-Jakob disease.
@nl
P2093
P1433
P1476
Cerebroventricular infusion of ...... iant Creutzfeldt-Jakob disease
@en
P2093
P304
P356
10.1016/J.JINF.2004.07.015
P577
2005-06-01T00:00:00Z